A joint research team affiliated with UNIST has developed a 3D-printed artificial tumor tissue capable of replicating the in ...

In a recent study published in Developmental Cell, researchers at Karolinska Institutet created a comprehensive map of ...

High-risk neuroblastoma kills roughly half of affected children because the tumor can switch cell identity and evade therapy.

A new publication shines a spotlight on HER3, a long-overlooked member of the ErbB receptor family, revealing its critical ...

Northwestern Medicine investigators have discovered new intracellular mechanisms that help specialized immune cells adapt and ...

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Optieum ...

Despite the efforts of the scientific community, cancer is still a leading cause of death worldwide. Immunotherapy, a ground-breaking strategy for cancer ...

Like cancer, placental cells multiply rapidly, invade tissues, and evade destruction by the immune system, but maternal ...

Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsChristine Chiou - Senior Vice President, ...

MELBOURNE, Australia and INDIANAPOLIS, May 8, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces ...